These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Long-term treatment with mammalian target of rapamycin inhibitor does not benefit patients with autosomal dominant polycystic kidney disease: a meta-analysis. Xue C; Dai B; Mei C Nephron Clin Pract; 2013; 124(1-2):10-6. PubMed ID: 24022660 [TBL] [Abstract][Full Text] [Related]
28. Better understanding of ADPKD results in potential new treatment options: ready for the cure? Meijer E; de Jong PE; Peters DJ; Gansevoort RT J Nephrol; 2008; 21(2):133-8. PubMed ID: 18446706 [TBL] [Abstract][Full Text] [Related]
29. Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrum. van Gulick JJ; Gevers TJ; van Keimpema L; Drenth JP Neth J Med; 2011 Sep; 69(9):367-71. PubMed ID: 21978978 [TBL] [Abstract][Full Text] [Related]
32. Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease. Rahbari-Oskoui F; Williams O; Chapman A Nephrol Dial Transplant; 2014 Dec; 29(12):2194-201. PubMed ID: 24463189 [TBL] [Abstract][Full Text] [Related]
33. Autosomal dominant polycystic kidney disease and pain - a review of the disease from aetiology, evaluation, past surgical treatment options to current practice. Badani KK; Hemal AK; Menon M J Postgrad Med; 2004; 50(3):222-6. PubMed ID: 15377813 [TBL] [Abstract][Full Text] [Related]
34. Do mTOR inhibitors still have a future in ADPKD? Perico N; Remuzzi G Nat Rev Nephrol; 2010 Dec; 6(12):696-8. PubMed ID: 21109768 [No Abstract] [Full Text] [Related]
35. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function. Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953 [TBL] [Abstract][Full Text] [Related]
36. Review of tolvaptan for autosomal dominant polycystic kidney disease. Baur BP; Meaney CJ Pharmacotherapy; 2014 Jun; 34(6):605-16. PubMed ID: 24706579 [TBL] [Abstract][Full Text] [Related]